Table 3:

Primary efficacy end point at a median of 6 months (range, 1–38 months)a

Aneurysm LocationAneurysm Occlusion
Occlusion Rateb (%)Total
<5050–95>95100
Anterior circulation (ICA)6 (6.1%)11 (11.2%)4 (4.1%)77 (78.6%)98
    Petrocavernous134
    Cavernous221216
    Carotid cave134
    Superior hypophyseal134
    Paraophthalmic222428
    Paraclinoid33
    Supraclinoid1135
    Posterior communicating artery1422431
    Anterior choroidal artery123
Anterior circulation distal to circle of Willis2 (5.3%)9 (23.7%)2 (5.3%)25 (65.8%)38
    ICA terminus11125
    Anterior cerebral artery (including AcomA)1179
    Middle cerebral artery171624
Posterior circulation1 (4.5%)2 (9.1%)3 (13.6%)16 (72.7%)22
    VA and VB junction178
    Posterior inferior cerebellar artery1225
    Basilar trunk1146
    Posterior cerebral artery33
Total9 (6%)22 (13%)9 (6%)118 (75%)158
  • Note:—AcomA indicates anterior communicating artery; VA, vertebral artery; VB, vertebrobasilar.

  • a Digital subtraction angiography follow-up was available in 158 aneurysms (86.8%).

  • b Occlusion rates at the latest follow-up are based on aneurysm volume calculated on pre-and posttreatment digital subtraction angiograms.